Secretary of Department of Biotechnology K VijayRaghavan said the growing economy has thrown up an "extraordinary opportunity" for "extraordinary synergy" across multiple sectors.
"If you talk of this region, you have AIIMS, and Safdarjung (Hospital) in the vicinity, and IIT-Delhi and JNU are not far. And, then you have National Institute of Immunology and South Campus (of Delhi University). But these institutions have grown in relative isolation of each other," he told a function at the All India Institute of Medical Sciences here.
"People say, we don't have the Stanfords and the CalTechs, and I say they are staring at our face," he said.
VijayRaghavan was speaking at the inauguration ceremony of AIIMS Cohort Study Centre in its premises.
Union Health Secretary C K Mishra said if there is one sphere where "we have failed, it is research".
"And it is not that we lack capabilities. We have a huge pool of talent but still not much being done in research area. Research needs a lot of investment and in India more often than not the immediate takes over the important.
Cohort studies are type of medical research used to investigate the causes of disease, establishing links between risk factors and health outcomes. They are planned in advance and carried out over a future period of time.
"All good institutions like AIIMS must come together and put their brains together... And I must say that if there is in any area where the investment needs to increase dramatically, it is research, and more so in the medical field," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
